Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Mallery

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Scientific Reports|July 3, 2026
TWEAK/FN14 inhibition synergizes with oncogene-directed tyrosine kinase inhibitors to overcome resistance across multiple driver contextsGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
Scientific Reports|May 4, 2026
Structure-guided identification and biological evaluation of reversible EGFR C797S inhibitorsGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
Cancers|May 13, 2026
Discovery of Structurally Distinct Covalent KRAS G12C Inhibitor Scaffolds Through Large-Scale In Silico Screening and Experimental ValidationGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
Plos One|June 29, 2018
Correction: Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platformScott M Morris, Janakiraman Subramanian, Esma S Gel, et al.
Plos One|April 28, 2018
Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platformScott M Morris, Janakiraman Subramanian, Esma S Gel, et al.
International Journal of Cancer|January 10, 2018
Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancerScott Morris, Anil Vachani, Harvey I Pass, et al.
Oncotargets and Therapy|May 12, 2015
Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision makingGlen J Weiss, Brandi R Hoff, Robert P Whitehead, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Scientific Reports|July 3, 2026
TWEAK/FN14 inhibition synergizes with oncogene-directed tyrosine kinase inhibitors to overcome resistance across multiple driver contextsGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
Scientific Reports|May 4, 2026
Structure-guided identification and biological evaluation of reversible EGFR C797S inhibitorsGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
Cancers|May 13, 2026
Discovery of Structurally Distinct Covalent KRAS G12C Inhibitor Scaffolds Through Large-Scale In Silico Screening and Experimental ValidationGlen J Weiss, Joseph C Loftus, David W Mallery, et al.
Plos One|June 29, 2018
Correction: Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platformScott M Morris, Janakiraman Subramanian, Esma S Gel, et al.
Plos One|April 28, 2018
Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platformScott M Morris, Janakiraman Subramanian, Esma S Gel, et al.
International Journal of Cancer|January 10, 2018
Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancerScott Morris, Anil Vachani, Harvey I Pass, et al.
Oncotargets and Therapy|May 12, 2015
Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision makingGlen J Weiss, Brandi R Hoff, Robert P Whitehead, et al.
Pageof 1